Platelet‐activating factor antagonists reduce excitotoxic damage in cultured neurons from embryonic chick telencephalon and protect the rat hippocampus and neocortex from ischemic injury in vivo
- 1 February 1993
- journal article
- research article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 34 (2) , 179-188
- https://doi.org/10.1002/jnr.490340205
Abstract
The neuroprotective effects of the platelet-activating factor (PAF) antagonists BN 52020 and BN 52021 were determined in a temperature-controlled model of transient forebrain ischemia in the rat (occlusion of both common carotid arteries combined with lowering of the mean arterial blood pressure to 40 mm Hg for 10 min). After 7 days of recirculation, the ischemic neuronal damage was evaluated histologically within the hippocampus and neocortex. Combined pre- and post-treatment with the PAF antagonists (2 × 25 mg/kg, s.c.) significantly reduced the resulting neuronal damage of the CA1 and CA3 hippocampal subfields and of the occipital and parietal cerebral cortex. The two PAF antagonists were also tested for their neuroprotective activity in primary neuronal cultures isoalted from embryonic chick telencephalon. Since an excessive activation of excitatory amino acid receptors is discussed to be of importance for the ischemic brain damage, the cultured neurons were exposed to the excitatory amino acid L-glutamate (1 mM) for a period of 60 min. Twenty hours after the excitotoxic insult, BN 52020- and BN 52021- treated cultured (1–100 μM) showed both a better preserved morphology, as well as a dose-dependent increase in cell viability and protein content compared to the control cultures. Our results demonstrate that the PAF antagonists BN 52020 and BN-52021 have the capacity to protect brain tissue against ischemic neuronal damge independent of hypothermic effects and are also capable of reducing excitotoxic damage of telencephalic neurons from chick embryos cultured in the absence of glial or endothelial cells. We thus propose that PAF plays an important role in the pathophysiology of ischemic/excitotoxic neuronal injury via a direct action on neurons.Keywords
This publication has 44 references indexed in Scilit:
- Recovery of Postischemic Brain Metabolism and Function Following Treatment with a Free Radical Scavenger and Platelet‐Activating Factor AntagonistsJournal of Neurochemistry, 1991
- Evidence for platelet-activating factor as a novel mediator in experimental stroke in rabbits.Stroke, 1990
- Platelet‐activating factor stimulates a Fos/Jun/AP‐1 transcriptional signaling system in human neuroblastoma cellsJournal of Neuroscience Research, 1989
- Postischemic moderate hypothermia inhibits CA1 hippocampal ischemic neuronal injuryNeuroscience Letters, 1989
- Production and effects of platelet-activating factor in the rat brainBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1988
- Cerebrovascular and Cerebrometabolic Effects of Intracarotid Infused Platelet-Activating Factor in RatsJournal of Cerebral Blood Flow & Metabolism, 1988
- Presence of specific binding sites for platelet-activating factor (PAF) in brainBiochemical and Biophysical Research Communications, 1988
- Effects of a platelet activating factor antagonist (BN 52021) on free fatty acids, diacylglycerols, polyphosphoinositides and blood flow in the gerbil brain: Inhibition of ischemia-reperfusion induced cerebral injuryBiochemical and Biophysical Research Communications, 1987
- Platelet activating factor receptor blockade enhances recovery after multifocal brain ischemiaLife Sciences, 1987
- Temporal profile of neuronal damage in a model of transient forebrain ischemiaAnnals of Neurology, 1982